AMSorb™- Bioresorbable Coronary Drug Eluting Stent System
The AMSorb™ Stent is a next-generation bioresorbable vascular drug-eluting stent, manufactured using the proprietary 3D-MAP technology. The product has been accepted into the National Special Review Channel for Innovative Medical Devices and is currently undergoing randomized controlled trials (RCT) studies.
For more product information, please feel free to contact us.
AMSorb™- Bioresorbable Coronary Drug Eluting Stent System
Product Features
● New stent manufacturing process with controlled material crystallinity for faster degradation rate
● Patented closed-cell stent design with excellent radial strength and structural stability
● Better stent crossing and delivery performances due to the flexible stent design
● Round stent struts with reduced cross-sectional areas for faster endothelialization and material resorption
Specifications
Stent diameter: 2.5mm~4.0mm
Stent length: 12mm~33mm
Results of AMSorb® FIM Trial 3 Years Follow-up: Restore, Repair and Resorption